Serum from pregnant women with gestational diabetes mellitus increases the expression of FABP4 mRNA in primary subcutaneous human pre-adipocytes.
10.5468/ogs.2017.60.3.274
- Author:
Lan LI
1
;
Se Jin LEE
;
Song Yi KOOK
;
Tae Gyu AHN
;
Ji Yeon LEE
;
Jong Yun HWANG
Author Information
1. Institute of Medical Science, Kangwon National University School of Medicine, Chuncheon, Korea. rapidhwang@kangwon.ac.kr
- Publication Type:Original Article
- Keywords:
Adiponectin;
Fatty acid-binding protein 4;
Pregnancy in diabetics
- MeSH:
Adipocytes;
Adiponectin;
Adipose Tissue;
Birth Injuries;
Blotting, Western;
Decidua;
Diabetes, Gestational*;
Enzyme-Linked Immunosorbent Assay;
Female;
Glucose Intolerance;
Humans;
Humans*;
Insulin Resistance;
Placenta;
Pregnancy;
Pregnancy Complications;
Pregnancy in Diabetics;
Pregnant Women*;
RNA, Messenger*;
Stillbirth
- From:Obstetrics & Gynecology Science
2017;60(3):274-282
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Gestational diabetes mellitus (GDM) is defined as glucose intolerance first detected during pregnancy. It can result in pregnancy complications such as birth injury, stillbirth. Fatty acid-binding protein 4 (FABP4), found in adipose tissue, is associated with insulin resistance, and type 2 diabetes. The aim of this study was to investigate whether FABP4 in the placenta and decidua of pregnant women with GDM is higher than that in normal pregnant women, and whether serum from pregnant women with GDM may cause adipocytes to secrete more FABP4 than does serum from a normal pregnant group. METHODS: We obtained placentas, deciduas, and serum from 12 pregnant women with GDM and 12 normal pregnant women and performed enzyme-linked immunosorbent assay, real time quantitative-polymerase chain reaction. We cultured human pre-adipocytes for 17 days with GDM and non-GDM serum and performed western blot, real time quantitative-polymerase chain reaction, and oil red O staining. RESULTS: Expression of FABP4 in serum, placenta and decidua of pregnant women with GDM was significantly higher than that in normal pregnant women. Serum from pregnant women with GDM increased the expression of FABP4 mRNA and decreased the expression of adiponectin mRNA in human pre-adipocytes significantly. Adipocyte cultured in GDM serum showed significantly greater lipid accumulation than those cultured in normal serum. CONCLUSION: Our results suggest that FABP4 is higher in placenta and decidua from pregnant women with GDM. Increased circulating FABP4 in maternal serum from pregnant women with GDM may originate from adipocytes and the placenta. Circulating FABP4 can induce increased insulin resistance and decreased insulin sensitivity.
